Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CPRT stock price vs COST: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at COST's multiple
Needs Annual EPS, COST P/E.
Implied fair value · at CPRT's multiple
Needs Annual EPS, CPRT P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
COPART INC · implied price per share
Reporting currency could not be verified.
COSTCO WHOLESALE CORP /NEW · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
CPRT · not enough data.
COST · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CARVANA CO.
CPRT vs CVNA
CARMAX INC
CPRT vs KMX
OPENLANE, Inc.
CPRT vs KAR
AUTONATION, INC.
CPRT vs AN
Tesla, Inc.
CPRT vs TSLA
FORD MOTOR CO
CPRT vs F
Walmart Inc.
CPRT vs WMT
TARGET CORP
CPRT vs TGT
KROGER CO
CPRT vs KR
DOLLAR GENERAL CORP
CPRT vs DG
AMAZON COM INC
CPRT vs AMZN
HOME DEPOT, INC.
CPRT vs HD
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CPRT can sustain its superior margins and modest growth while its middling quality score does not deteriorate, then CPRT looks attractive on relative valuation because it trades at far lower earnings and cash-flow multiples than COST.
CPRT trades at 18.3x P/E versus COST at 52.3x, while also carrying a lower EV/EBITDA multiple of 12.6x versus 37.2x. The model’s implied price of $83.11 versus the current $29.12 suggests 185.4% upside, but that COST-based gap is driven as much by COST’s much richer multiple as by CPRT’s own valuation.
Supporting Metrics
